(Date:5/12/2008)...AREMONT, Calif., May 12 /PRNewswire/ -- Keck Gradu...7, 2008, commencement ceremony will feature,the gr...es student, Eric,Tan, and the unveiling of KGI,s f...roud of Eric,s achievement in becoming the,first g...ewey, KGI,s senior,vice president for academic aff...
(Date:5/12/2008)...ake: VA Nurses Are ,the Compassionate Heart, of Sy.../ -- The Department of,Veterans Affairs (VA), the ... National Nurses Week by honoring six of its top p... heart of VA,s world-class health care,system," st...ake. "A great,deal of our reputation comes from th...
(Date:5/12/2008)... NASDAQ: CRME TSX: COM, VANCO...rma Corp.,(NASDAQ: CRME / TSX: COM) today announce...rst quarter of 2008 on the afternoon of Tuesday, M...all and webcast at 4:30pm,Eastern (1:30pm Pacific)...he conference call, please dial 416-641-6117 or,86...
(Date:5/12/2008)...s release is available in French . , Montreal,...shown that the administration of sildenafil protec...phy. This study was led by Dr. Christine Des Rosie...Heart Institute, in collaboration with Dr. Basil P...ersity Health Centre (MUHC) and Dr. Christian Desc...
Breaking Medicine News(10 mins):Health News:KGI 2008 Commencement Features First PhD Graduate, Biotech Painting 2Health News:Cardiome To Release 2008 First Quarter Results 2Health News:Cardiome To Release 2008 First Quarter Results 3Health News:Cardiome To Release 2008 First Quarter Results 4Health News:New approach to protect the hearts of patients with muscular dystrophy 2Health News:New approach to protect the hearts of patients with muscular dystrophy 3...ccine can prevent mice from developing a brain dis...arch that will be presented at the American// Acad...April 28 – May 5, 2007. Prion diseases, which incl...nic wasting disease, are fatal and there is no tre...
... ability to replace the tissue it sloughs off is c...Harvard Medical School published// in the May 4 is...or" of this regeneration process not only for skin...t, prostate, and urogenital tract. This master reg...
...airy Company of Johnstown, Pennsylvania, is recall... Plus Reduced Milk because they possibly// contain... unsafe. It has not been shown to be feasible to p...ilk itself to determine the presence or absence of...
...er the reduction in nicotine craving after smoking...icult it will be to quit smoking//, according to a... Dependence. In a study of 207 smokers, the resea... craving, withdrawal and mood after smoking the fi...
Other Medicine News:Health News:Vaccine Prevents Prion Disease in Mice 2Health News:Master Regulatory Gene of Epithelial Stem Cells Identified 2Health News:Reduction in Nicotine Craving Predicts Ability to Quit 2(Date:5/12/2008)...ELPHIA, May 12 /PRNewswire-USNewswire/ -- GlaxoSmi...ternational Group (BIG), a leading,academic breast...oups, the,Spanish Breast Cancer Cooperative Group ...se III study that will examine the role of TYKERB(...TTO (Neoadjuvant Lapatinib and/or,Trastuzumab Trea...
(Date:5/9/2008)...Fla., May 9 /PRNewswire-USNewswire/ -- Osteoarthri...ition that affects almost 50,million people in the...artilage in bone joints. The novel investigational...al analgesic, provided significant relief,for pati...eated with,placebo, and with fewer gastrointestina...
(Date:5/9/2008)...EGO, May 9 /- Ardea Bioscie...the discovery and development of,small- molecule t...nflammatory diseases, including gout, today announ...ce President, Finance and Operations and Chief,Fin...ign from our board of,directors shortly thereafter...
(Date:5/8/2008)...AND, May 8 /- DATATRAK Inte... services company focused on global,eClinical solu...rted its,operating results for the first quarter o...8, revenue decreased,approximately 41% to $2,088,0...000), or $(0.16) per share on both a basic and dil...
Breaking Medicine Technology:TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 2TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 3TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 4TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 5TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 6TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 7Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 2Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 3Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 4Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 5Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 2Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 3Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 4Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 5Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 6DATATRAK International Reports First Quarter Results for 2008 2DATATRAK International Reports First Quarter Results for 2008 3DATATRAK International Reports First Quarter Results for 2008 4DATATRAK International Reports First Quarter Results for 2008 5DATATRAK International Reports First Quarter Results for 2008 6DATATRAK International Reports First Quarter Results for 2008 7Health IT Now 21 Coalition to Discuss the Urgent Need to Pass Health IT Legislation 1310 1UNCOVERING THE TRUTH A Town Hall Meeting on Mental Health Parity 1306 1UNCOVERING THE TRUTH A Town Hall Meeting on Mental Health Parity 1306 2Virgin America Airline Debuts With MedAire Services 1303 1Virgin America Airline Debuts With MedAire Services 1303 2Virgin America Airline Debuts With MedAire Services 1303 3System Planning Corporation Launches New Asset Tracking and Monitoring System to Meet Pharmaceutical Industry Needs 1299 1System Planning Corporation Launches New Asset Tracking and Monitoring System to Meet Pharmaceutical Industry Needs 1299 2...ted At ASCO -- , CHICAGO – June 2, 2007 &nda...alfa-2b in stage III melanoma had a,significant an...,according to the results of the largest adjuvant ...lanoma. Results of the Phase,III study, led by the...ent of Cancer (EORTC) and supported by Schering-Pl...
...te in ASCO,Proceedings, HOUSTON, June 04, 2007 /PR...d with the US Oncology Research Network,presented ...trial,that compared the disease-free survival (DFS...or patients with high-risk breast,cancer. , The st...Dr.,David Loesch of Central Indiana Cancer Centers...
Other Medicine Technology:Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 2Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 3Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 4Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 5New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 2New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 3New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 4New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 5...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
Medicine Products: